CryOSA
Arden Hills, US · Founded 2018 · Delaware corporation · 2 known investors
Founders & leadership
LS
Laura StoltenbergExecutive
Board
DB
DF
Doug FrenchBoard director
JE
James EadieBoard director
DG
Donald GonzalesBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$7M disclosed across 2 rounds · 2018–2025
▶$6MraisedAug 2025 · 20 investors · BiotechnologyRule 506(b)
▶$6MraisedAug 2025 · 20 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Doug FrenchDirector
- James EadieDirector
- Donald GonzalesDirector
- David BelitzDirector
- Laura StoltenbergExecutive Officer, Director
- Offering amount
- $15M
- Amount sold
- $6M
- First sale
- Jun 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$997.3KraisedMay 2018 · 6 investors · Other Health CareRule 506(b)
▶$997.3KraisedMay 2018 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Donald GonzalesExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $997.3K
- Minimum investment
- $1
- First sale
- Apr 2018
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are CryOSA's investors?
- CryOSA's investors include Brightstone Venture Capital, Solas BioVentures.
- How much funding has CryOSA raised?
- CryOSA has disclosed $7M raised across 2 rounds.
- Where is CryOSA headquartered?
- CryOSA is headquartered in Arden Hills, US.